Trading Signals: SRNE Stock Price Prediction and Forecast (Thu. Jan. 25, 2007 - Fri. May. 13, 2022)(Sorrento Therapeutics, Inc. )
| SRNE latest price $25.2500 (0%) ($0.0000 - $0.0000) on Fri. Oct. 24, 2008. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 388.31% (three month average) | | RSI | 95 | | Latest Price | $25.2500(0%) | | Stocks Behave Similarly | Similar Stock List | | Weekly Trend | SRNE declines -3.2% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support SRNE advance at 0% a week (0% probability)
SHY(4%) TIP(3%) TLT(3%) LQD(2%) GLD(1%) | | Factors Impacting SRNE price | SRNE will decline at least -194.155% in a week (0% probabilities).
XLP(-8%) SPY(-7%) XLY(-6%) XLU(-6%) XLK(-6%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -194.155% (StdDev 388.31%) | | Hourly BBV | 0 () | | Intraday Trend | 0% | | | | | |
|
| Resistance Level | $36.09 | | 5 Day Moving Average | $25.25(0%) | | 10 Day Moving Average | $46.17(-45.31%) | | 20 Day Moving Average | $36.09(-30.04%) | | To recent high | -68.9% | | To recent low | 1% | | Market Cap | $5.854b | | | | | | |
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.June 16, 2020 - SRNE develops solution for Covid19 vaccines, treatment, and testing. But they're all in preclinical stage. |